N-(2-ethenylbenzyl)-N-ethylethanamine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-ethenylbenzyl)-N-ethylethanamine
• 英文别名: N-[(2-ethenylphenyl)methyl]-N-ethylethanamine
• 化学式: C₁₃H₁₉N
• 分子量: 189.301
• InChiKey: QIKIGSXUNRYDAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  [1,3-bis-(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(3-methyl-2-butenylidene)(tricyclohexylphosphine)ruthenium(II) 、 N-(2-ethenylbenzyl)-N-ethylethanamine 以 四氢呋喃 、 甲苯 为溶剂， 反应 2.5h， 以45%的产率得到[1,-bis(2,4,6-trimethylphenyl)2imidazolidineylidene]dichloro(2-N,N-diethylaminomethylbenzylidene)ruthenium
  参考文献：
  名称：

  具有六元 N 和 S 螯合环的潜在钌卡宾配合物

  摘要：

  通过第二代和第三代 Grubbs 催化剂与邻乙烯基苄基取代的胺或硫化物反应，合成了具有螯合 N-和 S-亚苄基配体的新型钌卡宾配合物。这些配合物显示出在开环复分解聚合和闭环复分解中的催化活性。

  DOI：

  10.1007/s11172-016-1327-x
• 作为产物：
  描述：

  异色满 在 potassium tert-butylate 、 氢溴酸 作用下， 以 1,4-二氧六环 、 叔丁醇 为溶剂， 反应 2.0h， 生成 N-(2-ethenylbenzyl)-N-ethylethanamine
  参考文献：
  名称：

  General procedure for the synthesis of ortho-vinylbenzyl-substituted amines, ethers, and sulfides

  摘要：

  A convenient procedure has been proposed for the synthesis ortho-vinylbenzyl-substituted ethers, amines, and sulfides via reaction of o-(2-bromoethyl)benzyl bromide with various nucleophiles.

  DOI：

  10.1134/s1070428013090145

文献信息

• Hoveyda–Grubbs catalysts with an N→Ru coordinate bond in a six-membered ring. Synthesis of stable, industrially scalable, highly efficient ruthenium metathesis catalysts and 2-vinylbenzylamine ligands as their precursors
  作者：Kirill B Polyanskii、Kseniia A Alekseeva、Pavel V Raspertov、Pavel A Kumandin、Eugeniya V Nikitina、Atash V Gurbanov、Fedor Ivanovich Zubkov

  DOI：10.3762/bjoc.15.73

  日期：——

  of this chemistry is further demonstrated by the tests of the novel catalysts (up to 10−2 mol %) in different metathesis reactions such as cross metathesis (CM), ring-closing metathesis (RCM) and ring-opening cross metathesis (ROCM).

  报道了一种新颖且有效的合成2-乙烯基苄胺的方法。这涉及通过烷基化和还原，然后进行霍夫曼裂解，从四氢异喹啉获得2-乙烯基苄胺配体。生成的2-乙烯基苄胺使我们能够获得新的Hoveyda-Grubbs催化剂，并通过NMR，ESIMS和X射线晶体学对其进行了全面表征。通过在不同复分解反应（如交叉复分解（CM），闭环复分解（RCM）和开环交叉复分解）中的新型催化剂（最高10 -2 mol％）的测试，进一步证明了该化学方法的实用性（ ROCM）。
• Modifier, modified and conjugated diene-based polymer and methods for preparing them
  申请人：LG Chem, Ltd.

  公开号：US10450387B2

  公开（公告）日：2019-10-22

  The present invention relates to a modifier and a modified and conjugated diene-based polymer including a functional group derived therefrom, and more particularly, provides a modifier including a compound represented by Formula 1, a modified and conjugated diene-based polymer including a functional group derived from the modifier and a repeating unit derived from a conjugated diene-based monomer, and methods for preparing them. In Formula 1, the definition of each substituent is the same as defined in the description of the invention.

  本发明涉及一种改性剂和一种改性和共轭二烯基聚合物，其中包括由此衍生的功能基团，更具体地提供了一种包括由化合物表示的 Formula 1 所代表的改性剂，一种包括从改性剂衍生的功能基团和从共轭二烯基单体衍生的重复单元的改性和共轭二烯基聚合物，以及它们的制备方法。在 Formula 1 中，每个取代基的定义与发明说明中定义的相同。
• [EN] HETEROCYCLIC COMPOUNDS AND THEIR USES<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS UTILISATIONS
  申请人：AMGEN INC

  公开号：WO2014152236A1

  公开（公告）日：2014-09-25

  Provided are certain pharmaceutical formulations of omecamtiv mecarbil and methods for their preparation and use.

  提供了奥米卡替夫美卡比尔的某些药物配方以及其制备和使用方法。
• Process for producing an oral sustained-release preparation of fasudil hydrochloride
  申请人：ASAHI KASEI PHARMA CORPORATION

  公开号：US20040131679A1

  公开（公告）日：2004-07-08

  Disclosed is an oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof, the preparation comprising at least one sustained-release coated particle comprising a core having a surface and a coating formed on the surface of the core, wherein the core contains the active ingredient and the coating comprises a coating base material and a specific insoluble auxiliary material, and wherein the preparation exhibits, with respect to the active ingredient, a specific dissolution rate, as measured by the dissolution test. By using the oral sustained-release preparation of the present invention, it becomes possible to surely control the release of fasudil hydrochloride from the preparation, so that the effect of the active ingredient is maintained for a long period of time. Therefore, the burden of the patient who has to take the preparation can be decreased and the compliance with respect to the administration of the preparation can be improved. Also disclosed is a method for evaluating an oral sustained-release preparation containing the active ingredient, wherein the evaluation is conducted with respect to the sustained-release ability of the active ingredient.

  本发明公开了一种口服缓释制剂，其含有从羟氯喹硫酸盐和其水合物组成的群中选择的至少一种活性成分，该制剂包括至少一种缓释包被粒子，其包括具有表面的核心和形成在核心表面上的涂层，其中核心含有活性成分，涂层包括涂层基材料和特定的不溶性辅助材料，且该制剂展现出特定的溶解速率，如溶解测试所测量的。通过使用本发明的口服缓释制剂，可以确保控制羟氯喹硫酸盐的释放，从而使活性成分的效果持续较长时间。因此，可以减轻服用制剂的患者的负担，并提高对制剂的管理的遵从性。还公开了一种评估口服缓释制剂的方法，该方法与活性成分的缓释能力有关。
• Liquid inks comprising treated colorant particles
  申请人：Samsung

  公开号：US20020086916A1

  公开（公告）日：2002-07-04

  A process of making a liquid ink comprising the steps of: (a) dissolving a polymer comprising units derived from at least a nitrogen-containing polymerizable monomer in a solvent with a Kauri-Butanol number greater than 30 to form a polymer solution; (b) dispersing colorant pigment particles in said polymer solution to form a colorant pigment dispersion; (c) removing at least some of said solvent from said colorant pigment dispersion to form treated colorant pigment particles; and (d) dispersing said treated colorant pigment particles in an organosol containing a carrier liquid having a Kauri-Butanol number less than 30.

  制备液体墨水的过程包括以下步骤：(a)将由至少一种含氮可聚合单体衍生的单元组成的聚合物溶解于Kauri-Butanol值大于30的溶剂中，形成聚合物溶液；(b)将颜料颗粒分散于聚合物溶液中，形成颜料分散液；(c)从颜料分散液中去除至少一部分溶剂，形成处理后的颜料颗粒；(d)将处理后的颜料颗粒分散于含有Kauri-Butanol值小于30的载体液体的有机溶胶中。